Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
April 16, 2024 - Page 4 of 4 - The Dermatology Digest
Subscribe
Search

Day: April 16, 2024

Biosimilar Update: Fresenius’ Actemra Biosimilar Now Available in the US

Fresenius’ Tyenne (tocilizumab-aazg), a biosimilar of Actemra (tocilizumab), is now available for use in the US. Tyenne is the first tocilizumab biosimilar with an intravenous and subcutaneous formulation approved by the FDA. The biosimilar received FDA approval on March 5, 2024. Tyenne is Fresenius’ third approved biosimilar available in the U.S. and the second within […]